Tech Portal Monaco
SEE OTHER BRANDS

Reporting on science and technology news in Monaco

Tech Portal Monaco: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tech Portal Monaco.

Press releases published on May 22, 2025

Onconetix, Inc. Announces Receipt of Additional Notice from Nasdaq

Onconetix, Inc. Announces Receipt of Additional Notice from Nasdaq

Cincinnati, OH, May 22, 2025 (GLOBE NEWSWIRE) -- Onconetix, Inc. (Nasdaq: ONCO) (the “Company”) announced that it received a Staff delisting letter from The Nasdaq Capital Market (“Nasdaq”) on May 20, 2025 indicating that the Company’s failure to file its …

Serina Therapeutics Appoints Stephen Brannan, M.D. to Board of Directors

Serina Therapeutics Appoints Stephen Brannan, M.D. to Board of Directors

- Renowned neuroscience drug developer joins to support strategic development of long-acting CNS therapeutics – HUNTSVILLE, AL, May 22, 2025 (GLOBE NEWSWIRE) -- Serina Therapeutics, Inc. (“Serina”) (NYSE American: SER), a clinical-stage biotechnology …

ESET participates in operation to disrupt the infrastructure of Danabot infostealer

ESET participates in operation to disrupt the infrastructure of Danabot infostealer

ESET Research has been tracking Danabot's activity since 2018 as part of a global effort that resulted in a major disruption of the malware's infrastructure. While primarily developed as an infostealer, Danabot also has been used to distribute additional …

Biodexa Pharmaceuticals PLC (“Biodexa” or the “Company”)  Notice of General Meeting

Biodexa Pharmaceuticals PLC (“Biodexa” or the “Company”) Notice of General Meeting

May 22, 2025 Biodexa Pharmaceuticals PLC (“Biodexa” or the “Company”) Notice of General Meeting Biodexa Pharmaceuticals PLC, (Nasdaq: BDRX), a clinical stage biopharmaceutical company developing a pipeline of innovative products for the treatment of …

Bio-Path Holdings to Host Corporate Update Conference Call on May 29, 2025

Bio-Path Holdings to Host Corporate Update Conference Call on May 29, 2025

HOUSTON, May 22, 2025 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (OTCQB:BPTH) a biotechnology company leveraging its proprietary DNAbilize® antisense RNAi nanoparticle technology to develop a portfolio of targeted nucleic acid cancer and obesity drugs, …

KMBIO announces Private sale for its P2P Exchange that connects Crypto World with Real Life

KMBIO announces Private sale for its P2P Exchange that connects Crypto World with Real Life

GUADALAJARA, Mexico, May 22, 2025 (GLOBE NEWSWIRE) -- The countdown has begun, KMBIO an P2P exchange focusing on LATAM market has officially opened its private sale round as part of its fundraising campaign. In the midst of the global expansion of digital …

GENFIT Reports First Quarter 2025 Financial Information

GENFIT Reports First Quarter 2025 Financial Information

Lille (France), Cambridge (Massachusetts, United States), Zurich (Switzerland), May 22, 2025 - GENFIT (Nasdaq and Euronext: GNFT), a late-stage biopharmaceutical company dedicated to improving the lives of patients with rare and life-threatening liver …

GENFIT : Information financière du premier trimestre 2025

GENFIT : Information financière du premier trimestre 2025

Lille (France), Cambridge (Massachusetts, États-Unis), Zurich (Suisse), le 22 mai 2025 – GENFIT (Nasdaq et Euronext : GNFT), société biopharmaceutique de stade clinique avancé engagée dans l’amélioration de la vie des patients atteints de maladies rares du …

Dianthus Therapeutics Appoints Simon Read, Ph.D., to Board of Directors

Dianthus Therapeutics Appoints Simon Read, Ph.D., to Board of Directors

Dr. Read brings >30 years of leadership and scientific expertise in the biopharmaceutical industry Previously served as CEO and Founder of Mariana Oncology until its acquisition by Novartis in 2024 and CSO of Ra Pharma until its acquisition by UCB in 2020 …

Rapid7 to Participate in Upcoming Investor Conferences

Rapid7 to Participate in Upcoming Investor Conferences

BOSTON, May 22, 2025 (GLOBE NEWSWIRE) -- Rapid7, Inc. (NASDAQ: RPD), a leader in extended risk and threat detection, today announced that the company will be attending the following conferences: The William Blair 45th Annual Growth Stock Conference in …

Inotiv, Inc. to Present at Jefferies Global Healthcare Conference 2025

Inotiv, Inc. to Present at Jefferies Global Healthcare Conference 2025

WEST LAFAYETTE, Ind., May 22, 2025 (GLOBE NEWSWIRE) -- Inotiv, Inc. (Nasdaq: NOTV) (the “Company” or “Inotiv”), a leading contract research organization specializing in nonclinical and analytical drug discovery and development services and research models …

Gyre Therapeutics Announces Proposed Underwritten Public Offering of Common Stock

Gyre Therapeutics Announces Proposed Underwritten Public Offering of Common Stock

SAN DIEGO, May 22, 2025 (GLOBE NEWSWIRE) -- Gyre Therapeutics (“Gyre”) (Nasdaq: GYRE), an innovative, commercial-stage biotechnology company focused on organ fibrosis, today announced that it has commenced an underwritten public offering of shares of its …

Outlook Therapeutics® Announces Proposed Public Offering of Common Stock and Warrants

Outlook Therapeutics® Announces Proposed Public Offering of Common Stock and Warrants

ISELIN, N.J., May 22, 2025 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company focused on enhancing the standard of care for bevacizumab for the treatment of retina diseases, today announced that it has commenced an …

Intchains Group Limited Reports First Quarter 2025 Unaudited Financial Results

Intchains Group Limited Reports First Quarter 2025 Unaudited Financial Results

Total revenues of US$18.2 million exceeds guidance, up 445.5% YoY Total ETH-based cryptocurrency units were approximately 7,023, up 23.2% QoQ Income from operations reach US$5.1 million, achieving turnaround from prior-year period SINGAPORE, May 22, 2025 ( …

Gyre Therapeutics’ Hydronidone Met the Primary Endpoint and Demonstrated Statistically Significant Fibrosis Regression in Pivotal Phase 3 Trial for the Treatment of CHB-associated Liver Fibrosis in China

Gyre Therapeutics’ Hydronidone Met the Primary Endpoint and Demonstrated Statistically Significant Fibrosis Regression in Pivotal Phase 3 Trial for the Treatment of CHB-associated Liver Fibrosis in China

Achieved statistically significant ≥1-stage fibrosis regression at Week 52 vs. placebo (52.85% vs. 29.84%, P=0.0002). Demonstrated favorable safety and tolerability profile: 4.88% serious adverse events vs. 6.45% for placebo; zero discontinuations due to …

 Skywork.ai Launches Globally, Introducing the World’s First DeepResearch-Powered Workspace Super Agents

Skywork.ai Launches Globally, Introducing the World’s First DeepResearch-Powered Workspace Super Agents

Singapore , May 22, 2025 (GLOBE NEWSWIRE) -- In May 2025, Skywork.ai officially entered the global stage, launching the world’s first AI Office Suite powered by DeepResearch technology, with full support for both English and Japanese to enhance …

CSGO Betting Sites: Thunderpick Named the Top U.S. Sportsbook for Counter-Strike: Global Offensive

CSGO Betting Sites: Thunderpick Named the Top U.S. Sportsbook for Counter-Strike: Global Offensive

New York City, May 22, 2025 (GLOBE NEWSWIRE) -- Thunderpick has redefined the CSGO betting experience for players across the U.S., offering everything a serious bettor could want in one streamlined platform. With competitive odds, real-time match coverage, …

GamblingNerd.com Announces: Prediction Markets Explode, Reshaping How We Forecast Global Events

GamblingNerd.com Announces: Prediction Markets Explode, Reshaping How We Forecast Global Events

Las Vegas, NV, May 22, 2025 (GLOBE NEWSWIRE) -- GamblingNerd.com, a leading industry reviewer, today highlights the monumental growth of prediction markets, platforms that are rapidly supplanting traditional polling methods and revolutionizing the …

AppTech Board Member Discloses Significant Common Stock Purchase

AppTech Board Member Discloses Significant Common Stock Purchase

CARLSBAD, Calif., May 22, 2025 (GLOBE NEWSWIRE) -- AppTech Payments Corp. (“AppTech or the “Company”) (OTCQB: APCX), announced Albert L. Lord, a member of its board of directors, informed the Company today of his intent to purchase up to one million shares …

Miningcoop Reshapes Cloud Mining: The Best Legal and Free Bitcoin Mining Platform for Beginners in 2025

Miningcoop Reshapes Cloud Mining: The Best Legal and Free Bitcoin Mining Platform for Beginners in 2025

London, UK, May 22, 2025 (GLOBE NEWSWIRE) -- As Bitcoin surpasses $100,000 and Dogecoin surges again due to renewed public attention, global crypto investors are seeking smarter, lower-risk, and passive income solutions. In response, leading mining …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service